Caligan Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	29
2025 Q4	–	Sell	-1,131,205	Closed	-$39.7M	–	25
2025 Q3	$45.4M	Buy	1,131,205 +59,947	+6%	+$2.25M	6.3%	6
2025 Q2	$35.6M	Buy	1,071,258 +369,978	+53%	+$11.2M	6.92%	4
2025 Q1	$20.5M	Buy	701,280 +75,000	+12%	+$2.49M	4.29%	9
2024 Q4	$20.6M	Buy	626,280 +46,563	+8%	+$2.19M	5.21%	7
2024 Q3	$25.8M	Buy	579,717 +65,006	+13%	+$2.95M	8.16%	6
2024 Q2	$22.2M	Buy	514,711 +30,000	+6%	+$1.08M	5.19%	8
2024 Q1	$14.2M	Buy	484,711 +42,878	+10%	+$1.15M	3.75%	8
2023 Q4	$9.84M	Buy	441,833 +437,000	+9,042%	+$9.79M	3.32%	7
2023 Q3	$120K	Hold	4,833	–	–	0.06%	13
2023 Q2	$137K	Buy	4,833 +500	+12%	+$12.4K	0.08%	13
2023 Q1	$99.5K	Hold	4,333	–	–	0.07%	11
2022 Q4	$122K	Buy	+4,333	New	+$122K	0.1%	11